Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV
2001; Elsevier BV; Volume: 358; Issue: 9293 Linguagem: Inglês
10.1016/s0140-6736(01)06662-4
ISSN1474-547X
AutoresMoses Sinkala, Julia P Stout, Sten H. Vermund, Robert L. Goldenberg, Jeffrey S. A. Stringer,
Tópico(s)Adolescent Sexual and Reproductive Health
ResumoUse of mass nevirapine therapy--universal provision of the drug without HIV testing--for prevention of perinatal HIV in high prevalence settings with extreme resource constraints is a controversial strategy. A quarter of pregnant Zambian women surveyed would prefer to receive nevirapine through a non-testing mass strategy, and most would support mass therapy as a policy if it would make the drug available to a larger proportion of the at-risk population.
Referência(s)